EMEA accepts naproxcinod MAA

EMEA accepted for filing an MAA from NicOx S.A. (Euronext:COX) for naproxcinod to relieve the signs and symptoms of primary osteoarthritis. The cyclooxygenase (COX)-inhibiting nitric oxide donator (CI...